Clinical Trials: Efficacy, Safety, and Inclusivity
Type:
Duration:
7 minutes
Featuring:
This is a video.
Use the controls provided by the embedded content to watch the video.
Overview
A greater understanding of population demographics, history, processes used in clinical trials can be crucial to promote vaccine acceptance. Here to discuss clinical trials the research necessary to evaluate safety, efficacy, and effectiveness is Dr. Hilary Aralis, Assistant Professor and Biostatician at the UCLA Fielding School of Public Health.
Learning objectives
- Acknowledge historical shortcomings with regards to inclusivity of minoritized populations in clinical trials
- Describe Black and Latinx populations representation in the COVID-19 clinical trials
- Explore the impact of vaccine efficacy; clinical trials estimated high vaccine efficacy among Black and Latinx populations and among minoritized communities when vaccination percentages increase, COVID-19 incidents correspondingly decrease
Added on 9/13/2021 ·
Last updated on 9/13/2021